— Know what they know.
/
Not Investment Advice
Also trades as: 0I5P.L (LSE) · $vol 0M

CBAY NASDAQ

CymaBay Therapeutics, Inc.
1W: +0.1% 1M: +0.8% 3M: +46.2% 1Y: +262.9% 3Y: +579.5% 5Y: +172.2%
$32.48
Last traded 2024-03-25 — delisted
NASDAQ · Healthcare · Biotechnology · $3.7B mcap · 97M float · 4.31% daily turnover
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2024-02-12
Earliest Filing
2024-02-12
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named CBAY in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
GILD GILEAD SCIENCES, INC. acquirer Target company in a merger agreement to be acquired by Gilead Sciences, Inc. 2024-02-12 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms